Terminated trial sought relief for rare, painful skin disease
NCT ID NCT05710185
Summary
This study aimed to test if a daily pill called deucravacitinib could help adults with palmoplantar pustulosis, a chronic skin disease that causes painful blisters on the palms and soles. Participants took the medication for 24 weeks while researchers checked if their skin symptoms and quality of life improved. The trial was terminated early after enrolling only 3 people.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PALMOPLANTAR PUSTULOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.